Speakers

Monica Taing

Board Member

ACHEM

Oren Giladi

Vice President R&D Drug Delivery and Technologies

BOL Pharma

Eyal Barad

Co-Founder & Chief Executive Officer

Cannabics Pharmaceuticals

Sud Agarwal

Chief Executive Officer

Cannvalate

Hunter Land

Vice President, Research and Development

Alterola Biotech Inc.

Loren DeFalco

Partner

CB1 Capital

Clifton Flack

Founder

CIITECH

Erich Veitenheimer

Partner

Cooley LLP

Daniel Knauss

Partner

Cooley LLP

Marcelo Pomeranz

Associate

Cooley LLP

Mikael Sodergren

Research Director & Managing Director

EMMAC Life Science & Sapphire Medical Clinics

David Traylor

Senior Director – Managing

Golden Eagle Partners

Alice Mead

Vice President - Public Policy

Greenwich Biosciences

Michael Woudenberg

Vice President of Commercialisation

InMed Pharmaceuticals Ltd

Frank Rice

President & Chief Scientist

Intidyn

Howard Goodwin

Managing Partner

Intrinsic Capital Partners

Guillermo Moreno Sanz

Scientific and Medical Director

Khiron Life Sciences Corp.

Nicolas Pateras

Managing Director

Materia Ventures

Nadiya Lisdover

Chief Regulatory Officer

MGC Pharmaceuticals Ltd.

Valentino Parravicini

Chief Scientific Officer

Oxford Cannabinoid Technologies

Marsha R. Rosner

Professor, Ben May Dept. for Cancer Research Gordon Center for Integrative Sciences

University of Chicago

Gregory Sotzing

Professor – Chemistry

University of Connecticut

Emmanuel Onaivi

Professor

William Paterson University

Oludare Odumosu

Chief Executive Officer

Zelira Therapeutics

Jay Blankenship

Vice President

Zylo Therapeutics

Karolina Urban

Vice President of Medical Programs

Avicanna

Mark Rosenfeld

Chief Executive Officer & Chief Science Officer

Ananda Scientific